Pamela Brambilla Bagatini
Pamela Brambilla Bagatini publishes mostly in Neurology, Neurology and Cellular and Molecular Neuroscience, on topics such as Neuroinflammation and Neurodegeneration Mechanisms, Parkinson's Disease Mechanisms and Treatments and Neuroscience and Neuropharmacology Research.
- World rank
- #5,728,879 of 7,710,434 ranked researchers
- Rank in Brazil
- #128,165 of 253,246
- Works
- 27
- Citations
- 616
- Citations per work
- 22.8
What does Pamela Brambilla Bagatini research?
Pamela Brambilla Bagatini's work is mostly in Neuroscience (20%), Medicine (17%), Agricultural and Biological Sciences (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1555.4%
- Life Sciences727.5%
- Health Sciences517.1%
- Medicine517.1%
- 1Neurology13% of their works
- 2Neurology12% of their works
- 3Cellular and Molecular Neuroscience8% of their works
- 4Epidemiology4% of their works
- 5Molecular Biology4% of their works
- 6Plant Science4% of their works
Research topics
- Neuroinflammation and Neurodegeneration Mechanisms
- Parkinson's Disease Mechanisms and Treatments
- Neuroscience and Neuropharmacology Research
- Insect and Pesticide Research
- Tryptophan and brain disorders
- Nerve injury and regeneration
- Neurological Disease Mechanisms and Treatments
- Acute Ischemic Stroke Management
Which keywords describe Pamela Brambilla Bagatini's research?
The keywords of their largest research topics: Neurodegeneration, Oxidative Stress, Ischemic Stroke, Microglia, Astrocytes, Synaptic Pruning, a-Synuclein and Parkinson's Disease.
- Vascular Cognitive Impairment
- Thrombolysis
- Neonicotinoids
- Honey Bees
- Cerebral Hypoperfusion
- Neurotransmission
- Depression
- Synaptic Plasticity
- Synaptic Pruning
- Microglia
- Oxidative Stress
- Neurodegeneration
- Ischemic Stroke
- Astrocytes
- Parkinson's Disease
- a-Synuclein
- GABAergic
- BDNF
- Endovascular Therapy
- Immune Activation
- Neurotrophins
- Tryptophan Metabolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Neurodegeneration112 topics
- Oxidative Stress93 topics
- Ischemic Stroke82 topics
- Microglia82 topics
- Astrocytes61 topic
- Synaptic Pruning61 topic
- Parkinson's Disease51 topic
- Synaptic Plasticity52 topics
- a-Synuclein51 topic
- Depression42 topics
- GABAergic31 topic
- Neurotransmission31 topic
- BDNF21 topic
- Cerebral Hypoperfusion21 topic
- Endovascular Therapy21 topic
- Honey Bees21 topic
- Immune Activation21 topic
- Neonicotinoids21 topic
- Neurotrophins21 topic
- Thrombolysis21 topic
- Tryptophan Metabolism21 topic
- Vascular Cognitive Impairment21 topic
Where does Pamela Brambilla Bagatini work?
Pamela Brambilla Bagatini's main affiliation in the publication record is Pontifícia Universidade Católica do Rio Grande do Sul, Brazil.
How many publications and citations does Pamela Brambilla Bagatini have?
OpenAlex counts 27 works and 616 citations for Pamela Brambilla Bagatini, an h-index of 13, ranking #5,728,879 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Pamela Brambilla Bagatini. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.